Improved Long-term Survival after Liver Resection for Hepatocellular Carcinoma in the Modern Era: Retrospective Study from HCV-endemic Areas (original) (raw)

Predictors of Recurrence in Hepatitis C Virus Related Hepatocellular Carcinoma after Hepatic Resection: A Retrospective Cohort Study

Ahmed Shehta

The Eurasian Journal of Medicine, 2014

View PDFchevron_right

Second Hepatic Resection for Recurrent Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

Shigekazu Takemura

World Journal of Surgery, 2008

View PDFchevron_right

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma

Ching-Hui Chuang

Medicina, 2022

View PDFchevron_right

The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients

Shinn-cherng Chen, Wan-long Chuang

Journal of Gastroenterology and Hepatology, 2015

View PDFchevron_right

Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort

Odile Goria

Clinics and Research in Hepatology and Gastroenterology, 2020

View PDFchevron_right

Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular Carcinoma

Terumasa Yamada

Annals of Surgery, 2006

View PDFchevron_right

Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus

Kiyoshi Hasegawa

Journal of Clinical Oncology, 2013

View PDFchevron_right

Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma

Hisashi Nakayama

BMC Gastroenterology, 2019

View PDFchevron_right

Hepatitis C and hepatocellular carcinoma

Francis Yao

Current Treatment Options in Oncology, 2001

View PDFchevron_right

Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy

Akihiro Tamori

American Surgeon, 2017

View PDFchevron_right

Hepatitis C Virus Infection is a Risk Factor for Tumor Recurrence after Resection of Small Hepatocellular Carcinomas

Cheng-yuan Hsia, Jaw-ching Wu

World Journal of Surgery, 2004

View PDFchevron_right

The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment

Shinya Maekawa

Internal Medicine

View PDFchevron_right

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area

Ting-Tsung Chang

Liver International, 2005

View PDFchevron_right

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C

Francisco Durazo, Mitsugi Shimoda

Liver Transplantation, 2004

View PDFchevron_right

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

Mohamed El-Kassas

Journal of Advanced Research, 2019

View PDFchevron_right

Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct‐acting antivirals

Akihiro Tamori

Journal of Surgical Oncology, 2020

View PDFchevron_right

Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma

Akihiro Tamori

Hepatology Research, 2002

View PDFchevron_right

Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis

Daniele Nicolini

Digestive and Liver Disease

View PDFchevron_right

Recurrent Hepatocellular Carcinoma in Liver Transplant Recipients with Hepatitis C

Ivan Zendejas

Journal of Gastrointestinal Cancer, 2010

View PDFchevron_right

Hepatitis C virus and hepatocellular carcinoma

Raffaella Romeo

Best Practice & Research Clinical Gastroenterology, 1999

View PDFchevron_right

Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment

Kazuhiro Nouso, Hepatoma Research

Hepatoma Research, 2019

View PDFchevron_right

Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals

xavier adhoute

European Journal of Gastroenterology & Hepatology, 2018

View PDFchevron_right

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

Fulvio Calise

Hepatology, 2006

View PDFchevron_right

Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2

Takashi Kumada

Journal of Medical Virology, 2001

View PDFchevron_right

Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C

Hepatoma Research

Hepatoma Research, 2022

View PDFchevron_right

De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus

Mohamed Nabil

European journal of gastroenterology & hepatology, 2017

View PDFchevron_right

Frequency of De Novo Hepatocellular Carcinoma after Direct-acting Antiviral Therapy for Chronic Hepatitis C: A Prospective Follow-up

Aneeqa Ahmad

Euroasian Journal of Hepato-Gastroenterology

View PDFchevron_right

Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region

Milotka Fabri

Journal of Gastroenterology, 2013

View PDFchevron_right

Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis

Rui Marinho

Digestive Diseases and Sciences, 2011

View PDFchevron_right

Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C

Joseph koffi DOKPO

Liver international : official journal of the International Association for the Study of the Liver, 2017

View PDFchevron_right

Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication

Akihiro Tamori

Clinical Infectious Diseases, 2019

View PDFchevron_right

Management of hepatitis C infection (regional guideline)

Kamran Lankarani

Hepat Mon, 2004

View PDFchevron_right